Related Experiment Videos
Initial hypertension treatment: one combination fits most?
Journal of the American Society of Hypertension : JASH
|March 19, 2011
Summary
Initial combination therapy for hypertension, particularly amlodipine plus an ACE inhibitor, offers superior blood pressure control and cardiovascular protection compared to monotherapy. A novel algorithm proposes single-tablet amlodipine + benazepril for most patients.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Growing global prevalence of uncontrolled hypertension.
- Physician inertia and patient nonadherence contribute to treatment challenges.
- Need for effective antihypertensive strategies.
Discussion:
- Initial combination therapy demonstrates superior efficacy over monotherapy for achieving blood pressure targets, rapidity of control, and patient adherence.
- Evidence suggests amlodipine + angiotensin-converting enzyme inhibitor combinations are most effective in reducing cardiovascular events.
- A novel algorithm proposes initiating treatment with a single amlodipine + benazepril tablet for most hypertensive patients.
Key Insights:
- Combination therapy is more effective than monotherapy for multiple hypertension outcomes.
- Amlodipine + ACE inhibitor combination shows promise for cardiovascular event reduction.
- Streamlined single-tablet therapy may improve patient adherence and outcomes.
Outlook:
- Further outcome trials are needed to validate the proposed amlodipine + benazepril algorithm.
- Investigating the risk/benefit ratio of this streamlined approach in stage I hypertension is crucial.
- Potential for improved global hypertension management through optimized initial treatment strategies.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...